vs

Side-by-side financial comparison of LifeStance Health Group, Inc. (LFST) and MERCURY SYSTEMS INC (MRCY). Click either name above to swap in a different company.

LifeStance Health Group, Inc. is the larger business by last-quarter revenue ($382.2M vs $232.9M, roughly 1.6× MERCURY SYSTEMS INC). LifeStance Health Group, Inc. runs the higher net margin — 3.1% vs -6.5%, a 9.5% gap on every dollar of revenue. On growth, LifeStance Health Group, Inc. posted the faster year-over-year revenue change (17.4% vs 4.4%). LifeStance Health Group, Inc. produced more free cash flow last quarter ($46.6M vs $45.7M). Over the past eight quarters, LifeStance Health Group, Inc.'s revenue compounded faster (12.8% CAGR vs 5.7%).

Lifestance Health (Lifestance) is an American outpatient behavioral health services provider. They provide their services in person and via tele-health. Their services include therapy, psychiatry, TMS, and ketamine therapies. They have landed in lawsuits multiple times over labor violations, leaking of customer information, and misleading investors.

Mercury Systems, Inc. is a technology company serving the aerospace and defense industry. It designs, develops and manufactures open architecture computer hardware and software products, including secure embedded processing modules and subsystems, avionics mission computers and displays, rugged secure computer servers, and trusted microelectronics components, modules and subsystems.

LFST vs MRCY — Head-to-Head

Bigger by revenue
LFST
LFST
1.6× larger
LFST
$382.2M
$232.9M
MRCY
Growing faster (revenue YoY)
LFST
LFST
+13.1% gap
LFST
17.4%
4.4%
MRCY
Higher net margin
LFST
LFST
9.5% more per $
LFST
3.1%
-6.5%
MRCY
More free cash flow
LFST
LFST
$940.0K more FCF
LFST
$46.6M
$45.7M
MRCY
Faster 2-yr revenue CAGR
LFST
LFST
Annualised
LFST
12.8%
5.7%
MRCY

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
LFST
LFST
MRCY
MRCY
Revenue
$382.2M
$232.9M
Net Profit
$11.7M
$-15.1M
Gross Margin
26.0%
Operating Margin
4.7%
-4.6%
Net Margin
3.1%
-6.5%
Revenue YoY
17.4%
4.4%
Net Profit YoY
264.1%
14.1%
EPS (diluted)
$-0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LFST
LFST
MRCY
MRCY
Q4 25
$382.2M
$232.9M
Q3 25
$363.8M
$225.2M
Q2 25
$345.3M
$273.1M
Q1 25
$333.0M
$211.4M
Q4 24
$325.5M
$223.1M
Q3 24
$312.7M
$204.4M
Q2 24
$312.3M
$248.6M
Q1 24
$300.4M
$208.3M
Net Profit
LFST
LFST
MRCY
MRCY
Q4 25
$11.7M
$-15.1M
Q3 25
$1.1M
$-12.5M
Q2 25
$-3.8M
$16.4M
Q1 25
$709.0K
$-19.2M
Q4 24
$-7.1M
$-17.6M
Q3 24
$-6.0M
$-17.5M
Q2 24
$-23.3M
$-10.8M
Q1 24
$-21.1M
$-44.6M
Gross Margin
LFST
LFST
MRCY
MRCY
Q4 25
26.0%
Q3 25
27.9%
Q2 25
31.0%
Q1 25
27.0%
Q4 24
27.3%
Q3 24
25.3%
Q2 24
29.5%
Q1 24
19.5%
Operating Margin
LFST
LFST
MRCY
MRCY
Q4 25
4.7%
-4.6%
Q3 25
2.0%
-3.8%
Q2 25
-0.9%
8.6%
Q1 25
0.5%
-8.2%
Q4 24
0.3%
-5.6%
Q3 24
0.0%
-6.6%
Q2 24
-5.1%
-3.2%
Q1 24
-5.6%
-21.9%
Net Margin
LFST
LFST
MRCY
MRCY
Q4 25
3.1%
-6.5%
Q3 25
0.3%
-5.6%
Q2 25
-1.1%
6.0%
Q1 25
0.2%
-9.1%
Q4 24
-2.2%
-7.9%
Q3 24
-1.9%
-8.6%
Q2 24
-7.5%
-4.3%
Q1 24
-7.0%
-21.4%
EPS (diluted)
LFST
LFST
MRCY
MRCY
Q4 25
$-0.26
Q3 25
$-0.21
Q2 25
$0.28
Q1 25
$-0.33
Q4 24
$-0.30
Q3 24
$-0.30
Q2 24
$-0.18
Q1 24
$-0.77

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LFST
LFST
MRCY
MRCY
Cash + ST InvestmentsLiquidity on hand
$248.6M
$335.0M
Total DebtLower is stronger
$282.8M
Stockholders' EquityBook value
$1.5B
$1.5B
Total Assets
$2.2B
$2.5B
Debt / EquityLower = less leverage
0.19×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LFST
LFST
MRCY
MRCY
Q4 25
$248.6M
$335.0M
Q3 25
$203.9M
$304.7M
Q2 25
$188.9M
$309.1M
Q1 25
$134.3M
$269.8M
Q4 24
$154.6M
$242.6M
Q3 24
$102.6M
$158.1M
Q2 24
$87.0M
$180.5M
Q1 24
$49.5M
$142.6M
Total Debt
LFST
LFST
MRCY
MRCY
Q4 25
$282.8M
Q3 25
$284.6M
Q2 25
$286.4M
Q1 25
$288.2M
Q4 24
$290.0M
Q3 24
$287.3M
Q2 24
$288.0M
Q1 24
$288.8M
Stockholders' Equity
LFST
LFST
MRCY
MRCY
Q4 25
$1.5B
$1.5B
Q3 25
$1.5B
$1.5B
Q2 25
$1.5B
$1.5B
Q1 25
$1.5B
$1.5B
Q4 24
$1.4B
$1.5B
Q3 24
$1.4B
$1.5B
Q2 24
$1.4B
$1.5B
Q1 24
$1.4B
$1.5B
Total Assets
LFST
LFST
MRCY
MRCY
Q4 25
$2.2B
$2.5B
Q3 25
$2.1B
$2.5B
Q2 25
$2.1B
$2.4B
Q1 25
$2.1B
$2.4B
Q4 24
$2.1B
$2.4B
Q3 24
$2.1B
$2.4B
Q2 24
$2.1B
$2.4B
Q1 24
$2.1B
$2.4B
Debt / Equity
LFST
LFST
MRCY
MRCY
Q4 25
0.19×
Q3 25
0.19×
Q2 25
0.19×
Q1 25
0.20×
Q4 24
0.20×
Q3 24
0.20×
Q2 24
0.20×
Q1 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LFST
LFST
MRCY
MRCY
Operating Cash FlowLast quarter
$57.6M
$51.6M
Free Cash FlowOCF − Capex
$46.6M
$45.7M
FCF MarginFCF / Revenue
12.2%
19.6%
Capex IntensityCapex / Revenue
2.9%
2.5%
Cash ConversionOCF / Net Profit
4.93×
TTM Free Cash FlowTrailing 4 quarters
$110.0M
$99.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LFST
LFST
MRCY
MRCY
Q4 25
$57.6M
$51.6M
Q3 25
$27.3M
$2.2M
Q2 25
$64.4M
$38.1M
Q1 25
$-3.1M
$30.0M
Q4 24
$62.3M
$85.5M
Q3 24
$22.7M
$-14.7M
Q2 24
$44.1M
$71.8M
Q1 24
$-21.8M
$-17.8M
Free Cash Flow
LFST
LFST
MRCY
MRCY
Q4 25
$46.6M
$45.7M
Q3 25
$17.0M
$-4.4M
Q2 25
$56.6M
$34.0M
Q1 25
$-10.3M
$24.1M
Q4 24
$56.0M
$81.9M
Q3 24
$17.7M
$-20.9M
Q2 24
$39.0M
$61.4M
Q1 24
$-26.9M
$-25.7M
FCF Margin
LFST
LFST
MRCY
MRCY
Q4 25
12.2%
19.6%
Q3 25
4.7%
-1.9%
Q2 25
16.4%
12.4%
Q1 25
-3.1%
11.4%
Q4 24
17.2%
36.7%
Q3 24
5.7%
-10.2%
Q2 24
12.5%
24.7%
Q1 24
-9.0%
-12.4%
Capex Intensity
LFST
LFST
MRCY
MRCY
Q4 25
2.9%
2.5%
Q3 25
2.8%
2.9%
Q2 25
2.2%
1.5%
Q1 25
2.2%
2.8%
Q4 24
1.9%
1.6%
Q3 24
1.6%
3.1%
Q2 24
1.6%
4.2%
Q1 24
1.7%
3.8%
Cash Conversion
LFST
LFST
MRCY
MRCY
Q4 25
4.93×
Q3 25
25.34×
Q2 25
2.33×
Q1 25
-4.36×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LFST
LFST

Segment breakdown not available.

MRCY
MRCY

Airborne$84.2M36%
Components$48.7M21%
Other End Applications$36.8M16%
Electronic Warfare$27.5M12%
Other Sensor And Effector Applications$23.9M10%
Space$11.9M5%

Related Comparisons